and Herman in a smaller series from New York did not confirm that age is of prognostic importance,20 nor did van Voorhis in a series of 762 patients from Iowa. 21 An early series in which radium alone was used failed to find any prognostic value in age.' 9 Series in which both surgery and radiotherapy have been given have not found age a significant factor in prognosis, 22-24 and indeed Gynning et al noted a different effect of age when two different treatment techniques were used for stage IB tumours (radical radiotherapy alone, bothl intracavity and external beam, or radical radiotherapy followed by elective hysterectomy).29 Other radiotherapy series have found that the effect of age on survival varies with stage.30 '1 These divergent and potentially confusing findings must result, at least in part, from the effect ofother prognostic factors. Age alone does not adequately indicate prognosis even when the effect of stage is also considered. In this study there was no evidence that young patients with cervical cancer treated by radical radiotherapy during the 1970s had a more aggressive form ofmalignancy. In most stages ofdisease their prognosis was similar to that ofolder patients, and in stage IB it was considerably better. We therefore conclude that younger age alone is not an indication for adjuvant treatment for cervical cancer. Recently qualitative tests have indicated that gastrointestinal bleeding during exercise may be an important contributory factor in sports anaemia. In six healthy men who walked 37 km on four consecutive days faecal haemoglobin content remained normal (reference range 01O-2-53 mg/g faeces) with no significant differences between values. In 28 marathon runners who refrained from taking drugs or food containing blood the median faecal haemoglobin content increased by 0-42 mg/g faeces (95% confidence interval 012 to 0-83 mg/g) from 1.06 (0-86 to 1-31) mg/g before the race. In 13 runners who had taken drugs before the race the corresponding increase in the median faecal haemoglobin content was 0.87 (-0.03 to 2.20) mg/g from the value before the race of 0-93 (0-46 to 1-55) mg/g.
Prolonged waling had no effect on gastrointestinal blood loss. Intense endurance exercise in the form of marathon running induced a significant but clinically unimportant increase. This may be exaggerated by the ingestion of drugs and assume importance in causing iron deficiency and sports anaemia. The use ofdrugs, particularly analgesics, by marathon runners should be actively discouraged.
Introduction
Sports or runners' anaemia is a well recognised complication of endurance exercise and has been variously attributed to plasma volume expansion, traumatic red cell haemolysis, and iron deficiency. This iron deficiency has been ascribed to haematuria, haemoglobinuria, iron loss through excessive sweating, impaired iron absorption, and, more recently, occult gastrointestinal blood loss.' A pilot study reported that occult gastrointestinal blood loss was not unusual after a marathon race,' and an increased loss was subsequently observed in trained athletes after racing.3
Subjects and methods
Prolonged walking-Six healthy men (mean age 28, range 24-39) walked three laps of a flat 12-3 km course on four consecutive days. Their diet was unrestricted except that no caffeine, alcohol, or drugs were allowed. Total daily faecal collections were made and a small sample (about 1 g) taken from each bowel movement for subsequent analysis of blood content.
Marathon running-Forty six volunteers (three women, 43 men) who were taking part in marathons (42-2 km) run in Aberdeen and Fortrose were studied. They were diverse in terms of age (mean 37, range 20-61), running ability (race time 218 minutes, range 161-290), and training (weekly training distance 67 km, range 10-176). Each subject completed a questionnaire detailing dietary habits, drugs taken, gastrointestinal disturbances, and training programme and provided a faecal sample (about 1 g) sometime in the two days preceding the race and from the first and second bowel movements passed after the race.
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The 46 subjects were retrospectively classified into two groups depending on whether their faecal occult blood results were likely to have been complicated by ingestion of drugs (n= 13) or not (n=28). Three subjects were eliminated from the study because ofabnormally high values before the race not attributable to drugs or food containing blood; and two who reported that they regularly ate a food containing blood (black pudding or sausage) and showed falsely high results throughout (mean 5 7 mg haemoglobin/g before the race and 3-6 and 8-0 mg/g after the race) were also excluded.
The table shows the distribution of positive slide test results for both groups. According to the HemoQuant assay, all tests yielded a comparable number of false positive results: Hema-Chek 60%, Hemoccult 44%, and Fecatwin S 57%.
Subjects who had not taken drugs (n=28)-The quantitative values in samples obtained before the race showed no correlation with age (r=0-243, p>0-1) or the weekly distance run in training (r=0-181, p>O-1), but there was a significant correlation with race time (r=0-384, p<005). Twenty subjects showed an increase in blood loss after the race (five in excess of normal, range 3-0-4-35 mg haemoglobin/g), but this attained significance only for the peak values ( (r=0 148), weekly distance run in training (r=0-265), or race time (r=0-216).
Subjects who had taken drugs (n= 13)-These subjects reported taking a drug before the race: aspirin (three), paracetamol (three), naproxen and aspirin (one); and (one each) naproxen, pseudoephedrine, clavulanic acid, diphenhydramine, aluminium hydroxide, and thyroxine with nitrazepam. One subject had an increased faecal blood loss (7-34 mg haemoglobin/g) before the race but four had excessive peak losses (3-46, 3-62, 4-74, and 13-08 mg/g) after the race. The subject who took aspirin and naproxen before running had a normal value for faecal occult blood before the race but a highly significant loss (13-08 mg/g) in the sample taken immediately after the race.
Of the 46 runners, 11 reported gastrointestinal disturbances during the race, particularly stomach cramp that was subjectively ascribed to low environmental temperature or intake of water before or during the race. Although these subjects had a significant increase (p<0 05) in blood loss after the race, this did not exceed that in the other subjects.
Discussion
Several recent studies suggesting that iron deficiency and the anaemia commonly found in endurance athletes may be due to gastrointestinal blood loss have been based on qualitative stool tests.267 These depend on the peroxidase activity of haemoglobin and have, as substantiated in this study, variable sensitivity.8 They are influenced not only by extraneous peroxidases derived from meat containing blood, certain vegetables, and the reducing activity of products containing vitamin C9 but also by the loss of peroxidase activity after the degradation ofhaemoglobin during transit through the bowel. These major drawbacks do not apply to the HemoQuant assay, which is quantitative, is not complicated by dietary factors other than ingestion ofblood, and measures both intact haemoglobin and its degradation products.
When evaluating faecal occult blood loss during exercise variables other than analytical ones must also be considered; these include sampling methods,'0 gut transit time,38 and the faecal mass and its water content."' The normal range of daily gastrointestinal blood loss has been established as 0-5-2-0 mg haemoglobin/g by radiochromium labelling methods'2"3; by HemoQuant assay we found a similar range (0-10-2-53 mg/g). During prolonged walking we did not show any significant day to day variation in faecal blood loss, and clearly this form of low intensity exercise had no adverse effects on the gastrointestinal tract.
In previous studies of marathon runners tests for faecal occult blood gave positive results in 8% (n=39),7 13% (n=63),6 and 22% (n=32)2 of runners after the race, but only peroxidase based screening tests were used and none excluded possible interference by medicinal or dietary factors. In our study 13 out of 46 (28%) marathon runners reported taking some form of drug before the race, and in two runners dietary factors invalidated the test results.
In the only previous study that measured actual gastrointestinal blood loss before and after races of between 10 and 42-2 km faecal blood increased in 20 out of 24 (83%) runners, from a mean loss of 0 99 mg haemoglobin/g before the race to a mean peak value of 3-96 mg/g after the race, although this last figure seems to have been biased by the inclusion of one subject with a blood loss after the race of 43-2 mg/g.3 Our study of a larger and more heterogeneous population who completed a marathon found only a minor median increase in blood loss after the race equivalent to 0-4 ml of whole blood a day after we had excluded results complicated by drug or dietary factors. Although this increase was significant, we regard it as having no clinical relevance in healthy athletes. More important, however, we showed that this increase was significantly exaggerated in those who took drugs, especially analgesics, before the race. We believe that the apparently common practice of taking analgesics before marathon running2 should be strongly discouraged.
The mechanism of the gastrointestinal blood loss associated with marathon running has been recently reviewed'4 and variously attributed to gut ischaemia, mechanical factors including "caecal slap"'5 and volvulus,'6 and aggravation of pre-existing occult or overt gut lesions.
Despite several studies the indications for echocardiography in ischaemic cerebrovascular disease and its impact on treatment remain undefined. In randomly tested patients the yield has been poor and echocardiography has not been reported as a screening method.' On the other hand, liberal use of echocardiography has been encouraged in young patients with cardiac disease, especially when angiograms have been unhelpful.2 3 The purpose of this study was, firstly, to identify useful predictors that would detect patients with embolic cardiac disease and, secondly, to discover the prevalence and type ofechocardiographic abnormalities in these patients.
Patients, methods, and results
During September 1983 to December 1985 we examined a total of 97 patients, most of whom were suffering from ischaemic infarction of the carotid territory. All patients were aged under 70 and the 55 patients aged 49 or less accounted for three quarters of all patients of that age in our own hospital's catchment area who suffered ischaemic strokes. Both two dimensional and M mode echocardiography was performed on all patients according to the recommendations of the American Society ofEchocardiography.4 The type ofequipment used was an ATL Mk 300C with a 3 0 MHz transducer. We chose the following as possible predictors of echocardiographic abnormalities: evidence of cardiac disease reported in the case notes, cardiac murmurs, electrocardiographic abnormalities, and increased size of the heart in radiographs. Carotid angiography of the affected artery was performed in 72 patients and the angiograms classified according to presence or absence of atheromatosis. 
